Invus Global Management, LLC

Director

Invus Global Management, LLC (Director) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in LXRX. Across 1 priced purchase filing, the average 21-session return was +40.0% from execution and +27.1% from disclosure (delay-adjusted; derived). The largest single filing was $2.0M of LXRX (1,538,462 sh × $1.30, as filed), executed Feb 2. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+40.0%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+27.1%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.0M

shares × price, as filed

Last traded

Feb 2

Filed Feb 4

Median ADV $72.6M across their filed names

Open performance→

Volume by month

Buys $2.0M Sells $66.6M

Shares × price, as filed · by filing month · past 24 months

Most traded names

LXRX LXRX 1 buy · 0 sells 1 filing SRRK

Scholar Rock Holding Corporation SRRK · 0 buys · 1 sell 1 filing

Recent filings

LXRXPURCHASE LEXICON PHARMACEUTICALS, INC. View filing → $2.0M
1,538,462 sh × $1.30
Exec Feb 2
Filed Feb 4 · 4:25 PM ET SRRKSALE Scholar Rock Holding Corporation View filing → $66.6M
1,600,000 sh × $41.65
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET